Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

35.57
Delayed Data
As of 4:00pm ET
 +0.36 / +1.02%
Today’s Change
28.25
Today|||52-Week Range
36.46
+10.19%
Year-to-Date
Novartis' Systemic Mastocytosis Drug Positive in Phase II
5:18pm / Zacks.com - Paid Partner Content
Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial
Jun 30 / Zacks.com - Paid Partner Content
Shire Stock Up Despite Mixed Data on Pipeline Candidate
5:18pm / Zacks.com - Paid Partner Content
McKesson Raises View Due to Accounting Changes, Stock Up
Jun 30 / Zacks.com - Paid Partner Content
AbbVie Humira Gains FDA Approval for Yet Another Indication
9:39am / Zacks.com - Paid Partner Content
141 Reasons to Love Biotech Stocks
Jun 30 / MotleyFool.com - Paid Partner Content
Transition (TTHI) Stock Up on News of Acquisition by Opko
9:39am / Zacks.com - Paid Partner Content
Pfizer's Rally Is Losing Momentum
Jun 30 / TheStreet.com - Paid Partner Content
Bristol-Myers, PsiOxus Strike Immuno-Oncology Collaboration
9:01am / Zacks.com - Paid Partner Content
AbbVie, J&J's Imbruvica Gets Breakthrough Therapy Status
Jun 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.21
Today’s open35.15
Day’s range35.12 - 35.65
Volume19,327,637
Average volume (3 months)39,547,280
Market cap$213.5B
Dividend yield3.37%
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.80%
Revenue growth (last year)-1.52%
P/E ratio29.2
Price/Sales4.13
Price/Book3.36

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.20+0.24%
AGNPRAAllergan plc+6.08+0.73%
MRKMerck+0.33+0.57%
BMYBristol-Myers Squibb+0.23+0.31%
Data as of 4:02pm ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs